Community teamwork to improve addiction care in Vietnam
Strengthening Addiction Care Continuum through Community Consortium in Vietnam
This project trains community health workers and family members in Vietnam to provide ongoing, medication-supported care for people with opioid addiction.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-11138631 on NIH RePORTER |
What this research studies
You would be part of an effort where local health workers and families help people with opioid addiction get and stay on treatment. Researchers will first meet with people who use opioids, their families, and community health staff in three regions (Ninh Binh, Da Nang, and Can Tho) to learn about barriers and needs. They will use those findings to design a Community Care Consortium that offers personalized, community-based support including medication-assisted treatment and follow-up. The consortium will then be implemented and tested in those regions to see if it improves continuity of care.
Who could benefit from this research
Good fit: People in Vietnam with opioid use disorder who are willing to receive care through local community health workers and involve family support would be the ideal participants.
Not a fit: People who do not have opioid use disorder, live outside the study regions in Vietnam, or cannot engage with community health workers or family-based support are unlikely to benefit.
Why it matters
Potential benefit: If successful, it could make medication-based treatment easier to access locally, keep people engaged in care longer, and reduce relapse and overdose.
How similar studies have performed: Medication-assisted treatment and community-support programs have improved outcomes elsewhere, but combining community health workers and family-led care in Vietnam is a newer approach being adapted here.
Where this research is happening
Los Angeles, United States
- University of California Los Angeles — Los Angeles, United States (Active)
Researchers
- Principal investigator: Li, Li — University of California Los Angeles
- Study coordinator: Li, Li
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.